Multiplex reverse transcriptase-polymerase chain reaction screening in childhood acute myeloblastic leukemia

被引:52
作者
Strehl, S
König, M
Mann, G
Haas, OA
机构
[1] St Anna Childrens Hosp, CCRI, A-1090 Vienna, Austria
[2] St Anna Childrens Hosp, Ludwig Boltzmann Inst Cytogenet Diag, A-1090 Vienna, Austria
关键词
D O I
10.1182/blood.V97.3.805
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the incidence of leukemia-specific rearrangements, 60 cases of childhood acute myeloblastic leukemia and transient myeloproliferative disorder were screened with a novel multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) assay, and the results were correlated with the cytogenetic findings. The RT-PCR assay detects 28 different fusion genes and more than 80 different fusion transcript variants, RNA was isolated from methanol/acetic acid-fixed cells that had been routinely prepared for cytogenetic analysis. Nine different fusion transcripts were found in 40% of the cases, whereas 78.3% of the cases had abnormal karyotypes, Two cases with a t(6;11) and an MLL/AF6 gene fusion were missed cytogenetically, Conversely, cytogenetic analysis revealed 10 other well-defined chromosome rearrangements. Although cytogenetic analysis reveals a much broader range of abnormalities, multiplex RT-PCR serves as quality control and provides the essential information for minimal residual disease studies, Moreover, discrepant findings lead to the detection of new rearrangements on the molecular genetic level. (C) 2001 by The American Society of Hematology.
引用
收藏
页码:805 / 808
页数:4
相关论文
共 28 条
[1]  
Allford S, 1999, BRIT J HAEMATOL, V105, P198
[2]  
Barnard DR, 1996, LEUKEMIA, V10, P5
[3]   Nineteen cases of the t(1;22)(p13;q13) acute megakaryoblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group [J].
Bernstein, J ;
Dastugue, N ;
Haas, OA ;
Harbott, J ;
Heerema, NA ;
Huret, JL ;
Landman-Parker, J ;
LeBeau, MM ;
Leonard, C ;
Mann, G ;
Pages, MP ;
Perot, C ;
Pirc-Danoewinata, H ;
Roitzheim, B ;
Rubin, CM ;
Slociak, M ;
Viguie, F .
LEUKEMIA, 2000, 14 (01) :216-218
[4]   The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial [J].
Grimwade, D ;
Walker, H ;
Oliver, F ;
Wheatley, K ;
Harrison, C ;
Harrison, G ;
Rees, J ;
Hann, I ;
Stevens, R ;
Burnett, A ;
Goldstone, A .
BLOOD, 1998, 92 (07) :2322-2333
[5]  
HENIC N, 1995, LEUKEMIA, V9, P1409
[6]   Atlas of genetics and cytogenetics in oncology and haematology, an interactive database [J].
Huret, JL ;
Le Minor, S ;
Dorkeld, F ;
Dessen, P ;
Bernheim, A .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :349-351
[7]  
Jaju RJ, 1999, BLOOD, V94, P773
[8]   Detection of karyotypic aberrations in acute myeloblastic leukaemia:: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML [J].
Krauter, J ;
Peter, W ;
Pascheberg, U ;
Heinze, B ;
Bergmann, L ;
Hoelzer, D ;
Lübbert, M ;
Schlimok, G ;
Arnold, R ;
Kirchner, H ;
Port, M ;
Ganser, A ;
Heil, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) :72-78
[9]   Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials [J].
Langabeer, SE ;
Walker, H ;
Rogers, JR ;
Burnett, AK ;
Wheatley, K ;
Swirsky, D ;
Goldstone, AH ;
Linch, DC .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (04) :925-928
[10]   Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the UK MRC AML trials [J].
Langabeer, SE ;
Walker, H ;
Gale, RE ;
Wheatley, K ;
Burnett, AK ;
Goldstone, AH ;
Linch, DC .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (04) :736-739